Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
Wednesday, April 29, 2015 1:57:06 PM
My expectation is that the company will sell for $170 to $195 million this year, with only q3 and q4 surpassing last year's revenue numbers.
The stock price will remain undervalued regardless....as there is no way it cannot break even and post minor profits with sales above $170 million per year, regardless of endorsements.
Revenues are under pressure because of protein spiking chatter, the complete lack of exciting and engaging communication and because BB.com is guiding traffic away from Musclepharm products towards Glanbia, Cellucor and new brands....hurting the growth in the short term.
The company has done a lot of right things, but lately it has gotten a little introvert and defensive in it's communication, which has made it drop a little bit in popularity among some customers and partners.
Right now, a realistic price target is $9.5....if Brad really delivered what was promised, hell the stock price would be $20....
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM